Abbott, St. Jude Medical Post Gains

St. Jude expects full-year profit in the range of $2.30 to $2.32 a share. Analysts, on average, are looking for $2.31 for the year.

After Tuesday's close, Genentech (DNA Quote) announced product sales above expectations, but said a few charges affected GAAP and non-GAAP EPS by about 13 cents collectively.

Adjusted profit rose 11% year over year to $863 million, or 81 cents a. Revenue rose 17% to roughly $3.4 billion.

The company garnered upgrades from Citigroup and Cowen and Co. on Wednesday. Shares were up 6. 1%, at $83.96.